Defence Therapeutics Inc DTCFF

$0.17 −0.01 (3.20%)
View Full Chart
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover DTCFF, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.

Trading Information

Previous Close Price
$0.18
Day Range
$0.17–0.17
52-Week Range
$0.17–0.76
Bid/Ask
$0.09 / $0.20
Shares Outstanding
76.11M
Market Cap
$10.03M
Volume/Avg
200 / 11,454

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
—
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological-/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The company has one operating segment, being research and development.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
—
Total Number of Employees
5

Valuation

Metric
DTCFF
Price/Earnings (Normalized)
—
Price/Book Value
—
Price/Sales
—
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
DTCFF
Quick Ratio
3.37
Current Ratio
3.42
Interest Coverage
−12.23
Quick Ratio
DTCFF

Profitability

Metric
DTCFF
Return on Assets (Normalized)
−105.85%
Return on Equity (Normalized)
—
Return on Invested Capital (Normalized)
−146.88%
Return on Assets
DTCFF

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|&&$s%vkLOCK|l@YT$136B
Regeneron Pharmaceuticals Inc
REGN
LOCK|pw&$%q>LOCK|!j<N$98B
Moderna Inc
MRNA
LOCK|&F$hcXLOCK|>#$80B
argenx SE ADR
ARGX
LOCK|T>RK?l&LOCK|np$59B
BeOne Medicines Ltd ADR
ONC
LOCK|C$<CSDlLOCK|Ng$47B
Royalty Pharma PLC Class A
RPRX
LOCK|jBH^x>rLOCK|x<<h$31B
Incyte Corp
INCY
LOCK|z?FD^#wLOCK|CD$$24B
BioNTech SE ADR
BNTX
LOCK|^kw!X^LOCK|t#$21B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|>D&nZcLOCK|?^Yq!$20B
Jazz Pharmaceuticals PLC
JAZZ
LOCK|#M!V&$LOCK|lG#$16B

Sponsor Center